Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLA? 16mm, TiZr, Loxim: medical device reports filed with FDA

465 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

465
device reports naming the brand
0% of all MAUDE reports · about 68 a year
69
reports, 12 months to August 2026
96 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

465 medical device reports received by FDA name the brand "BLT ?3.3mm NC, SLA? 16mm, TiZr, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

69 reports arrived in the 12 months to August 2026, down 28% from 96 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (74.2%), loss of osseointegration (15.3%) and fracture (1.7%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01223Sep 2021: 4Oct 2021: 4Nov 2021: 4Dec 2021: 42022Jan 2022: 4Feb 2022: 3Mar 2022: 3Apr 2022: 5May 2022: 5Jun 2022: 5Jul 2022: 7Aug 2022: 9Sep 2022: 0Oct 2022: 2Nov 2022: 3Dec 2022: 82023Jan 2023: 6Feb 2023: 6Mar 2023: 6Apr 2023: 5May 2023: 7Jun 2023: 8Jul 2023: 3Aug 2023: 4Sep 2023: 4Oct 2023: 3Nov 2023: 9Dec 2023: 82024Jan 2024: 6Feb 2024: 6Mar 2024: 12Apr 2024: 7May 2024: 8Jun 2024: 7Jul 2024: 8Aug 2024: 7Sep 2024: 13Oct 2024: 10Nov 2024: 11Dec 2024: 62025Jan 2025: 4Feb 2025: 8Mar 2025: 5Apr 2025: 4May 2025: 0Jun 2025: 23Jul 2025: 9Aug 2025: 3Sep 2025: 5Oct 2025: 9Nov 2025: 8Dec 2025: 22026Jan 2026: 3Feb 2026: 7Mar 2026: 5Apr 2026: 4May 2026: 6Jun 2026: 11Jul 2026: 5Aug 2026: 4

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0511012019: 3420192020: 3520202021: 4720212022: 5420222023: 6920232024: 10120242025: 8020252026: 452026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%465
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84.1%391
Voluntary report0%0
User facility report0%0
Distributor report15.9%74
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate34574.2%62.8%
Loss of osseointegration7115.3%22.4%
Fracturea broken bone81.7%1.6%
Difficult to insertthe device was hard to insert40.9%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis15834%
Painpain, site not specified13529%
Tissue damage5211.2%
Inflammationinflammation388.2%
Hemorrhage/blood loss/bleeding245.2%
Swelling/ edema214.5%
Fistula194.1%
Abscessa collection of pus102.2%
Hyperresponsive to stimuli91.9%
Hypersensitivity/allergic reaction71.5%
Swellingswelling40.9%
Numbnessnumbness20.4%
Failure of implant10.2%
Inadequate osseointegration10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLA? 16mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports4653,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLA? 16mm, TiZr, Loxim reports

How many FDA reports name BLT ?3.3mm NC, SLA? 16mm, TiZr, Loxim?

465 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 69 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (74.2%), loss of osseointegration (15.3%), fracture (1.7%) and difficult to insert (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84.1%) and distributor reports (15.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLA? 16mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.